The efficacy of different immunotherapy strategies to NSCLC patients after resistance to EGFR-TKIs: A retrospective study

被引：0
|
作者：
Huang, Jiuyan [1 ]
Wei, Chunhua [1 ]
Wang, Huijuan [1 ,2 ]
机构：
[1] Zhengzhou Univ, Dept Med Oncol, Affiliated Canc Hosp, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China
[2] Henan Canc Hosp, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2024年 / 47卷 / 11期
关键词：
Advanced NSCLC; Immunotherapy; EGFR-TKIs resistance;
D O I：
10.1016/j.asjsur.2024.05.257
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：5078 / 5079
页数：2
相关论文
共 50 条
  • [1] Revolutionizing NSCLC Treatment: Immunotherapy Strategies for EGFR-TKIs Resistance
    Tian, Jin
    Shi, Zhiqi
    Zhao, Lili
    Liu, Peng
    Sun, Xiaojun
    Long, Lin
    Zang, Jianhua
    Xiao, Jun
    CLINICAL RESPIRATORY JOURNAL, 2024, 18 (12):
  • [2] Bisphosphonates enhance EGFR-TKIs efficacy in advanced NSCLC patients with EGFR activating mutation: A retrospective study
    Huang, Chu-ying
    Wang, Li
    Feng, Cheng-jun
    Yu, Ping
    Cai, Xiao-hong
    Yao, Wen-xiu
    Xu, Yong
    Liu, Xiao-ke
    Zhu, Wen-jiang
    Wang, Yan
    Zhou, Jin
    Lu, You
    Wang, Yong-sheng
    ONCOTARGET, 2016, 7 (41): : 66480 - 66490
  • [3] Efficacy of EGFR-TKIs for EGFR Mutant NSCLC Patients with Central Nervous System Metastases: A Retrospective Analysis
    Koyama, K.
    Saida, Y.
    Abe, T.
    Satokata, M.
    Mishina, Y.
    Sato, K.
    Shoji, S.
    Tanaka, T.
    Nozaki, K.
    Ichikawa, K.
    Miyabayashi, T.
    Ota, T.
    Fujimori, F.
    Ito, R.
    Kondo, R.
    Hiura, T.
    Okajima, M.
    Miura, S.
    Watanabe, S.
    Matsumoto, N.
    Tanaka, H.
    Kikuchi, T.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2132 - S2132
  • [4] Efficacy and Safety of Anlotinib Plus EGFR-TKIs in Slowly or Locally Progressing NSCLC after Adjuvant Therapy with EGFR-TKIs
    Ye, J.
    Liu, J.
    Yang, Y.
    Lv, W.
    Xu, W.
    Xia, P.
    Wang, L.
    Zhu, L.
    Hu, J.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S554 - S554
  • [5] A retrospective study of the survival and subsequent treatment after EGFR-TKIs for NSCLC at Chiba University Hospital
    Iwasawa, Shunichiro
    Imai, Chiaki
    Saeki, Hiromi
    Ikari, Jun
    Tada, Yuji
    Takiguchi, Yuichi
    Tatsumi, Koichiro
    ANNALS OF ONCOLOGY, 2018, 29
  • [6] Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
    Wen, Miaomiao
    Xia, Jinghua
    Sun, Ying
    Wang, Xuejiao
    Fu, Xianghui
    Zhang, Yanning
    Zhang, Zhipei
    Zhou, Yongan
    Li, Xiaofei
    BIOLOGICS-TARGETS & THERAPY, 2018, 12 : 183 - 190
  • [7] Serum proteomic study on EGFR-TKIs target treatment for patients with NSCLC
    Wu, Xuan
    Liang, Wenhua
    Hou, Xue
    Lin, Zhong
    Zhao, Hongyun
    Huang, Yan
    Fang, Wenfeng
    Zhao, Yuanyuan
    Wu, Jingxun
    Yang, Yunpeng
    Xue, Chong
    Hu, Zhihuang
    Zhang, Jing
    Zhang, Jianwei
    Ma, Yuxiang
    Zhou, Ting
    Qin, Tao
    Zhang, Li
    ONCOTARGETS AND THERAPY, 2013, 6 : 1481 - 1491
  • [8] Efficacy and Safety of Third-Generation EGFR-TKIs Combined with Radiotherapy for Advanced NSCLC with Typical EGFR Mutations: A Retrospective Study
    Zhang, Wen-xuan
    Xue, Hui-chan
    Zhao, Ye
    Xu, Shuang-bing
    CURRENT MEDICAL SCIENCE, 2025,
  • [9] Efficacy of 3rd Generation EGFR-TKIs After Failing First or Second Generation EGFR-TKIs in EGFR Mutation-Positive NSCLC (ROOT-EGFR)
    Jung, H. A.
    Hong, S.
    Park, J.
    Park, M. R.
    Sun, J.
    Lee, S.
    Ahn, J. S.
    Ahn, M.
    Park, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S853 - S853
  • [10] Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
    Wei, Zhigang
    Ye, Xin
    Yang, Xia
    Zheng, Aimin
    Huang, Guanghui
    Li, Wenhong
    Wang, Jiao
    Han, Xiaoying
    Meng, Min
    Ni, Yang
    ONCOTARGET, 2017, 8 (34) : 56714 - 56725
12345